AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING MOXIFLOXACIN OR SALTS THEREOF

WIPO Patent Application WO2001010408

A3

The invention relates to an aqueous pharmaceutical composition containing moxifloxacin and less than 20 ppb iron.

KUEHN BERND (DE)
MAHLER HANS-FRIEDRICH (DE)
EISELE MICHAEL (DE)

PCT/EP2000/007099

September 07, 2001

July 25, 2000

Click for automatic bibliography generation  

BAYER AG (DE)
KUEHN BERND (DE)
MAHLER HANS FRIEDRICH (DE)
EISELE MICHAEL (DE)

A61K9/08; A61K9/00; A61K31/4709; A61K47/02; A61K47/10; A61K47/26; A61P31/04; (IPC1-7): A61K9/08; A61K31/4709; A61K47/10; A61K47/26

WO2000018386A2	2000-04-06
WO2000025765A2	2000-05-11

BALLOW C ET AL.: "Absolute bioavailability of moxifloxacin.", CLINICAL THERAPEUTICS, vol. 21, no. 3, March 1999 (1999-03-01), pages 513 - 522, XP000978350, ISSN: 0149-2918
WISE R ET AL.: "Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 43, no. 6, June 1999 (1999-06-01), pages 1508 - 1510, XP002158890, ISSN: 0066-4804
SIEFERT HM ET AL.: "Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: A comparison in humans and other mammalian species.", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 43, no. SUPPL. B, May 1999 (1999-05-01), pages 69 - 76, XP000978348, ISSN: 0305-7453

View/Download PDF      PDF Help

Previous Patent: FACILITATING THE PRESERVATION OF SIGHT BY INCREASING OPTIC NERVE, CHOROIDAL AND RETINAL BLOOD FLOW

Next Patent: NON-CRYSTALLINE CEFUROXIME AXETIL SOLID DISPERSANT, PROCESS FOR PREPARING SAME AND COMPOSITION FOR O...